NovaMed to Distribute Epilepsy Drug for Sanofi-Aventis
publication date: Jul 28, 2008
NovaMed Pharmaceuticals added a sixth drug to the list of pharmaceutical products it distributes in China for Sanofi-Aventis. Starting immediately, NovaMed will promote and distribute Depakine®, an epilepsy drug that is the most widely prescribed anti-convulsant in China. More details...
Stock Symbol: (NYSE: SNY)
Sorry... this feature or article is only available to subscribers.